Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > AGM

<< Previous

Bullboard Posts

Next >>

Comment by steamfitteron Jun 28, 2022 9:30pm

286 Views

Post# 34789267

RE:RE:AGM

In my opinion it was agood meeting.

Phase II NMIBC ClinicalStudy Timeline (Projected)

Between 2019 to 2023 projected 100 to 125 patients
Fast track 2020
Breakthrough designation Projected end of 2022-2023.

Patient Follow up (Projected)2019 to 2025

data Lock/Clinical study submission (projected) 2025

Commercialization Phase (Projected) 2023-2025.